STOCK TITAN

Embla Medical Recognized for Leadership in Accessibility and International Reach

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags
Embla Medical (NASDAQ: EMBLA), a global mobility solutions provider, has received two major recognitions. The company was named to Forbes' inaugural Accessibility 100 list alongside tech giants like Google and Apple, acknowledging its innovations in prosthetics and orthotics. With over 2,100 patents, Embla operates through brands including Össur, Fior & Gentz, and College Park, while running ForMotion patient care clinics globally. Additionally, Embla received the 2025 President of Iceland's Export Award, highlighting its growth from a 20-person company in 1992 to its current status with 4,000 employees across 36 countries. The company maintains its focus on improving life quality for those with mobility challenges through innovative solutions and personalized care.
Embla Medical (NASDAQ: EMBLA), fornitore globale di soluzioni per la mobilità, ha ricevuto due importanti riconoscimenti. L'azienda è stata inserita nella prima lista Accessibility 100 di Forbes, insieme a giganti tecnologici come Google e Apple, in riconoscimento delle sue innovazioni in protesi e ortesi. Con oltre 2.100 brevetti, Embla opera attraverso marchi come Össur, Fior & Gentz e College Park, gestendo inoltre cliniche di cura per pazienti ForMotion in tutto il mondo. Inoltre, Embla ha ricevuto il Premio per l'Export 2025 dal Presidente dell'Islanda, evidenziando la sua crescita da un'azienda di 20 persone nel 1992 a una realtà con 4.000 dipendenti in 36 paesi. L'azienda mantiene il focus sul miglioramento della qualità della vita delle persone con sfide di mobilità attraverso soluzioni innovative e cure personalizzate.
Embla Medical (NASDAQ: EMBLA), proveedor global de soluciones de movilidad, ha recibido dos importantes reconocimientos. La compañía fue incluida en la lista inaugural Accessibility 100 de Forbes junto a gigantes tecnológicos como Google y Apple, reconociendo sus innovaciones en prótesis y ortesis. Con más de 2,100 patentes, Embla opera bajo marcas como Össur, Fior & Gentz y College Park, y gestiona clínicas de atención al paciente ForMotion a nivel mundial. Además, Embla recibió el Premio a la Exportación 2025 del Presidente de Islandia, destacando su crecimiento desde una empresa de 20 personas en 1992 hasta su estado actual con 4,000 empleados en 36 países. La compañía mantiene su enfoque en mejorar la calidad de vida de quienes enfrentan desafíos de movilidad mediante soluciones innovadoras y atención personalizada.
글로벌 모빌리티 솔루션 제공업체 Embla Medical(NASDAQ: EMBLA)은 두 가지 주요 수상을 받았습니다. 이 회사는 Google, Apple과 같은 기술 대기업과 함께 Forbes의 첫 Accessibility 100 명단에 선정되어 보철 및 정형외과 분야의 혁신을 인정받았습니다. 2,100개 이상의 특허를 보유한 Embla는 Össur, Fior & Gentz, College Park 등의 브랜드를 통해 운영되며 전 세계적으로 ForMotion 환자 치료 클리닉을 운영하고 있습니다. 또한 Embla는 1992년 20명 규모의 회사에서 현재 36개국에 4,000명의 직원을 둔 기업으로 성장한 점을 인정받아 아이슬란드 대통령 수출상을 2025년에 수상했습니다. 이 회사는 혁신적인 솔루션과 맞춤형 케어를 통해 이동성 문제를 가진 사람들의 삶의 질 향상에 집중하고 있습니다.
Embla Medical (NASDAQ : EMBLA), fournisseur mondial de solutions de mobilité, a reçu deux distinctions majeures. L'entreprise a été intégrée à la première liste Accessibility 100 de Forbes, aux côtés de géants technologiques tels que Google et Apple, en reconnaissance de ses innovations dans les prothèses et orthèses. Avec plus de 2 100 brevets, Embla opère via des marques telles qu'Össur, Fior & Gentz et College Park, tout en gérant des cliniques de soins ForMotion à l'échelle mondiale. De plus, Embla a reçu le Prix à l'Exportation 2025 décerné par le Président de l'Islande, soulignant sa croissance d'une entreprise de 20 personnes en 1992 à une société comptant aujourd'hui 4 000 employés dans 36 pays. L'entreprise reste focalisée sur l'amélioration de la qualité de vie des personnes confrontées à des défis de mobilité grâce à des solutions innovantes et des soins personnalisés.
Embla Medical (NASDAQ: EMBLA), ein globaler Anbieter von Mobilitätslösungen, hat zwei bedeutende Auszeichnungen erhalten. Das Unternehmen wurde in die erste Accessibility 100-Liste von Forbes aufgenommen, gemeinsam mit Technologieriesen wie Google und Apple, als Anerkennung für seine Innovationen im Bereich Prothetik und Orthopädietechnik. Mit über 2.100 Patenten operiert Embla über Marken wie Össur, Fior & Gentz und College Park und betreibt weltweit ForMotion-Patientenkliniken. Zudem erhielt Embla den Exportpreis 2025 des Präsidenten von Island, der das Wachstum von einem 20-köpfigen Unternehmen im Jahr 1992 zu einem aktuellen Status mit 4.000 Mitarbeitern in 36 Ländern hervorhebt. Das Unternehmen konzentriert sich weiterhin darauf, die Lebensqualität von Menschen mit Mobilitätseinschränkungen durch innovative Lösungen und personalisierte Betreuung zu verbessern.
Positive
  • Recognition in Forbes' inaugural Accessibility 100 list alongside major tech companies like Google, Apple, and Microsoft
  • Strong intellectual property portfolio with over 2,100 patents
  • Significant global expansion from 20 employees in 1992 to 4,000 employees across 36 countries
  • Received the President of Iceland's Export Award for 2025, demonstrating international business success
Negative
  • None.

Company honored by Forbes Magazine for Championing Accessibility and by Iceland's President for Excellence in Global Exports

REYKJAVÍK, Iceland, June 18, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, is being internationally recognized for its pioneering role in enhancing peoples' mobility and its business leadership, the company announced today.

Forbes Magazine has named Embla Medical to its first-ever global Accessibility 100 list, recognizing the company's history of innovative prosthetics, neuro orthotics and bracing solutions, and high-quality patient care services. The prestigious list recognizes, for the first time, innovators in the field of accessibility for people with disabilities.

Embla Medical is home to a number of leading mobility brands, including Össur, a leading global provider of prosthetics and bracing and supports solutions; Fior & Gentz, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels. 

Since its founding in 1971, Embla Medical has secured more than 2,100 patents and numerous award-winning designs and is renowned for advancing the Orthotic & Prosthetic (O&P) industry. The company also operates ForMotion patient care clinics, which provide innovative solutions, expert guidance, and personalized care and support to patients in countries around the globe.

The Forbes list was curated through interviews with more than 400 accessibility leaders across 15+ countries. Organizations were selected based on impact, innovation, and potential to drive systemic change across industries. In addition to Embla Medical, other companies on the list include global tech giants Google, Apple, Microsoft, Meta, and Sony, and apparel brand Nike, with whom Össur partnered for the Nike Sole on its Össur Cheetah® sports blade.

"Accessibility is a fascinating space that has never been captured like this before," said Alan Schwarz, Forbes Assistant Managing Editor who spearheaded the project. "There are lone innovators, juggernaut tech companies, startups. They are revolutionizing how people get around, learn, communicate, work, play sports, travel, and so much more. Their impact on people's lives is monumental - and will only be getting more so soon."

"We are honored to have received this recognition as a purpose-driven company that is passionately committed to improving the quality of life for people experiencing chronic mobility challenges," said Sveinn Sölvason, Embla Medical's President and CEO. "From designing award-winning mobility solutions to operating our network of patient care clinics, we remain singularly focused on providing innovative mobility solutions that help more people live a Life Without Limitations."

According to Sölvason, Embla Medical has also received the President of Iceland`s Export Award for 2025, recognizing the company's success as an international business.

"This recognition speaks to the dedication, and global impact of our entire team, and accepting the award from President Halla Tómasdóttir was a very meaningful moment," Sölvason said, noting that the first time the company received this honor was in 1992, as a small Icelandic company employing around 20 people at that time.

"Today," he continued, "we have more than 4,000 employees, operating in 36 countries, and countless individuals rely on our solutions every day. What hasn`t changed over the years is our purpose: to improve the lives of people facing mobility challenges. Although we have grown globally, our roots remain in Iceland, shaped by a culture of resilience, innovation, and ambition. This award is not just a celebration of how far we've come - it's also a reminder of the importance of continued investment in new innovation and the conditions that allow global businesses to thrive."

Contact:
Edda H. Geirsdottir
VP of Corporate Communications
egeirsdottir@emblamedical.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/embla-medical-hf-/r/embla-medical-recognized-for-leadership-in-accessibility-and-international-reach,c4166021

 

Cision View original content:https://www.prnewswire.com/news-releases/embla-medical-recognized-for-leadership-in-accessibility-and-international-reach-302485053.html

SOURCE Embla Medical hf.

FAQ

What major recognitions did Embla Medical (EMBLA) receive in 2025?

Embla Medical received two major recognitions in 2025: inclusion in Forbes' inaugural Accessibility 100 list and the President of Iceland's Export Award.

How many patents does Embla Medical (EMBLA) currently hold?

Embla Medical has secured more than 2,100 patents throughout its history since founding in 1971.

What is the current global presence of Embla Medical (EMBLA)?

Embla Medical currently operates in 36 countries with more than 4,000 employees worldwide.

Which major brands are part of Embla Medical's (EMBLA) portfolio?

Embla Medical's portfolio includes Össur (prosthetics and bracing), Fior & Gentz (neuro orthotics), College Park (custom prosthetics), and ForMotion patient care clinics.

What companies were listed alongside Embla Medical in Forbes' Accessibility 100?

The list included major tech companies such as Google, Apple, Microsoft, Meta, Sony, and Nike, with whom Embla's subsidiary Össur partnered for the Nike Sole project.
EMBLA

:EMBLA

EMBLA Rankings

EMBLA Latest News

EMBLA Stock Data